Medicare Spending Forecast For Leqembi Reflects CMS Angst About Alzheimer’s Drug Costs

Medicare is the lead US payer for Alzheimer's drugs. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet